News
Announcement Regarding Completion of a Tender Offer for Nihon Chouzai Co., Ltd.
2025.09.17
We are pleased to announce that AP86 Co., Ltd., funded by a fund serviced by Advantage Partners, Inc. (AP) and an affiliated fund of LYFE Capital Investment Management Ltd (LYFE), has successfully completed a tender offer (the “Tender Offer”) for the common shares issued by Nihon Chouzai Co., Ltd. (Nihon Chouzai; Securities Code: 3341).
Nihon Chouzai, guided by its mission “To give people the closest possible support,” is a leader in Japan’s healthcare sector. Its operations are centered on its core Dispensing Pharmacy Business, complemented by a Pharmaceutical Manufacturing and Sales Business and a Medical Professional Staffing and Placement Business. By combining the Nihon Chouzai Group’s expertise with AP’s universal management improvement know-how gained through numerous investment achievements and LYFE’s global network in the life sciences field, we will accelerate Nihon Chouzai’s further growth and ensure its lasting corporate development.
For further details regarding this Tender Offer, please refer to the “Notice Regarding Completion of Tender Offer for Shares of NIHON CHOUZAI Co., Ltd. (Securities Code: 3341) by AP86 Co., Ltd., dated Sep 17, 2025”.
〈Overview of NIHON CHOUZAI Co., Ltd.〉
Company Name: NIHON CHOUZAI Co., Ltd.
Representative: Kazunori Ogi, President & CEO
Location: 9F Tamachi Tower, 5-33-11, Shiba, Minato-ku, Tokyo 108-0014
Business: Dispensing Pharmacy Business, Pharmaceutical Manufacturing and Sales
Business, Medical Professional Staffing and Placement Business
Website: https://www.nicho.co.jp/corporate/